Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Nature Communications
|
November 25, 2018
Quantum-enhanced sensing using non-classical spin states of a highly magnetic atom
Thomas Chalopin, Chayma Bouazza, Alexandre Evrard, et al.
European Journal of Medicinal Chemistry
|
April 2, 2003
Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell lines
Jean Yves Winum, Jean Luc Bouissière, Isabelle Passagne, et al.
Drug Metabolism and Drug Interactions
|
June 7, 2013
Lexical fields of predictive and personalized medicine
Thierry Mathieu, Laurent Bermont, Jean-Christophe Boyer, et al.
Annales De Biologie Clinique
|
December 5, 2012
[Lexical fields of predictive and personalized medicine]
Thierry Mathieu, Laurent Bermont, Jean-Christophe Boyer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 13, 2003
Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression
Isabelle Passagne, Alexandre Evrard, Jean-Yves Winum, et al.
Anti-Cancer Drugs
|
March 22, 2006
Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study
Raphaelle Fanciullino, Alexandre Evrard, Pierre Cuq, et al.
Head & Neck
|
October 16, 2010
Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives
Benjamin Lallemant, Alexandre Evrard, Guillaume Chambon, et al.
Cancer Chemotherapy and Pharmacology
|
July 21, 2021
Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy
Fanny Leenhardt, Marie Alexandre, Severine Guiu, et al.
Toxicology Reports
|
May 14, 2019
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Bérénice Framery, Marian Gutowski, Karen Dumas, et al.
Pharmacogenomics
|
March 3, 2012
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations
Joseph Ciccolini, Alexandre Evrard, Lithaty M'Batchi, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Nature Communications
|
November 25, 2018
Quantum-enhanced sensing using non-classical spin states of a highly magnetic atom
Thomas Chalopin, Chayma Bouazza, Alexandre Evrard, et al.
European Journal of Medicinal Chemistry
|
April 2, 2003
Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell lines
Jean Yves Winum, Jean Luc Bouissière, Isabelle Passagne, et al.
Drug Metabolism and Drug Interactions
|
June 7, 2013
Lexical fields of predictive and personalized medicine
Thierry Mathieu, Laurent Bermont, Jean-Christophe Boyer, et al.
Annales De Biologie Clinique
|
December 5, 2012
[Lexical fields of predictive and personalized medicine]
Thierry Mathieu, Laurent Bermont, Jean-Christophe Boyer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 13, 2003
Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression
Isabelle Passagne, Alexandre Evrard, Jean-Yves Winum, et al.
Anti-Cancer Drugs
|
March 22, 2006
Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study
Raphaelle Fanciullino, Alexandre Evrard, Pierre Cuq, et al.
Head & Neck
|
October 16, 2010
Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives
Benjamin Lallemant, Alexandre Evrard, Guillaume Chambon, et al.
Cancer Chemotherapy and Pharmacology
|
July 21, 2021
Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy
Fanny Leenhardt, Marie Alexandre, Severine Guiu, et al.
Toxicology Reports
|
May 14, 2019
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Bérénice Framery, Marian Gutowski, Karen Dumas, et al.
Pharmacogenomics
|
March 3, 2012
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations
Joseph Ciccolini, Alexandre Evrard, Lithaty M'Batchi, et al.
Page
of 7